ONSD and Neurotoxicity in Liver Transplant
Optic Nerve Sheath Diameter as A Predictor of Early Tacrolimus Neurotoxicity After Living Donor Liver Transplantation
1 other identifier
observational
100
1 country
1
Brief Summary
This is a diagnostic test accuracy study. The investigators measure optic nerve sheath diameter (ONSD) by ultrasound on the eye during living donor liver transplantation operation at 5 minutes after reperfusion to predict the occurrence of early tacrolimus neurotoxicity after liver transplantation. We measured the ONSD at 4 timings: (T1) Post induction and before surgical incision, (T2) Portal vein clamping, (T3) 5 minutes after reperfusion, and (T4) 30 min after reperfusion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedFirst Submitted
Initial submission to the registry
January 6, 2019
CompletedFirst Posted
Study publicly available on registry
January 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 23, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 23, 2021
CompletedApril 12, 2022
April 1, 2022
2.2 years
January 6, 2019
April 7, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Early tacrolimus neurotoxicity
definition that will be considered when neurological events (visual disturbance, altered level of consciousness, confusion, psychosis, seizure, encephalopathy, tremors and/or coma or change in the pattern of the preexisting cirrhotic neurological changes ) appeared in the absence of central pontine myelinolysis, central nervous system infection, stroke, or hemorrhage within the first 4 weeks after LT and symptoms improved after dose modification of CNI therapy
28 days after transplantation
Secondary Outcomes (4)
Time and presentation of neurotoxicity
28 days after transplantation
Intensive Care Unit stay
until discharge from ICU for 1 year
Hospital Length of stay
until discharge from the hospital for 1 year
Mortality
three months after transplant
Interventions
Patients were placed in the supine position with their eyes closed, and a thick gel layer was applied to the closed upper eyelid. The 7.5-MHz linear probe was placed on the gel without excessive pressure and adjusted to the proper angle for displaying the entry of the optic nerve into the globe. The intensity of the ultrasound was adjusted to display optimal contrast between the retrobulbar echogenic fat tissue and the vertical hypoechoic band. An ultrasound beam was focused on the retrobulbar area using the lowest possible acoustic power that could measure ONSD. The ONSD was measured 3 mm behind the optic disc. Measurements were performed in the transverse and sagittal planes of both eyes, and the final ONSD value was calculated by average 4 measured values. We measured the ONSD at 4 timings: (T1) Post induction and before surgical incision, (T2) Portal vein clamping, (T3) 5 minutes after reperfusion, and (T4) 30 min after reperfusion.
Eligibility Criteria
Adult (\>= 18 years) recipients undergoing living donor liver transplantation
You may qualify if:
- All adult patients of both sex undergoing living donor liver transplantation operation
You may not qualify if:
- History of optic neuritis
- History of Arachnoid cyst of the optic nerve.
- History of eye trauma
- History of optic nerve trauma.
- Familial amylodotic polyneuropathy
- Wilson disease.
- Patient planned to use immunosuppression regimen other than tacrolimus.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gastroenerology Surgical Center - Liver transplantation program
Al Mansurah, Dakahlia Governorate, 35516, Egypt
Related Publications (1)
Elsedeiq M, Abdelkhalek M, Abozeid KM, Habl MS, Elmorshedi MA, Yassen AM, Emara MM. Intraoperative Optic Nerve Sheath Diameter as a Predictor of Early Tacrolimus Neurotoxicity after Living Donor Liver Transplantation. Anaesth Crit Care Pain Med. 2023 Feb;42(1):101178. doi: 10.1016/j.accpm.2022.101178. Epub 2022 Nov 25.
PMID: 36442803DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Mahmoud M. Elsedeiq, MD
Lecturer of anaesthesia and intensive care
- STUDY DIRECTOR
Amr M. Yassin, MD
professor of anaesthesia and surgical intensive care
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor of anaesthesia and surgical intensive care
Study Record Dates
First Submitted
January 6, 2019
First Posted
January 10, 2019
Study Start
January 1, 2019
Primary Completion
March 23, 2021
Study Completion
March 23, 2021
Last Updated
April 12, 2022
Record last verified: 2022-04